This research was supported by Pronex – FAP-DF and FINEP L Dalc

This research was supported by Pronex – FAP-DF and FINEP. L. Dalcin, R.C. Silva and F. Paulini

received fellowships from CAPES. “
“Cryopreservation of PBMC is commonly used to preserve cells for prospective phenotypic and functional analysis in a wide range of infectious diseases and clinical vaccine studies. Ku-0059436 chemical structure An increasing number of investigations have focused on diseases affecting cellular immunity, including HIV [28] and [44], tuberculosis [37] and cancer [15], using PBMC for assay readout. In the context of vaccine and pathogenesis studies, effective and reproducible cryopreservation protocols for PBMC enable the setup of large sample repositories which in turn allows comparative multi-center studies and avoids

inter- and intra-laboratory assay variability during analysis of independently isolated fresh samples [38]. Accurate quantification of cellular immune responses is important in such studies because changes in the antigen-specific T-cell response indicate the efficiency of a new test vaccine as it affects the initiation of antibody synthesis and cellular immune responses. However, the time interval for reliable results after PBMC isolation is quite narrow [5]. This makes comparison of results between laboratories difficult and, following Luyet and Hodapp [26], has led to the continuous development Selleckchem Epacadostat of new cryopreservation methods have been continuously developed. At temperatures below −130 °C, metabolic activity is significantly reduced and cells can theoretically be stored for long periods without effects on properties and function [18]. Suboptimal cryopreservation results Thalidomide in a significant decrease of cell viability and number, and may also cause alterations of the cellular phenotype and a reduction of the immunogenic response to specific antigens [6], [22], [24], [29], [32], [34], [46] and [48]. Cryopreservation

can affect antigen processing capability and cause a disproportionate loss of responses to protein antigens [27]. There is also a relationship between post-thawing viability and the capacity for functional responses [48]. However, preservation of antigen-specific T-cell response is under permanent critical discussion. Moreover, the most common used method of freezing PBMC, fetal calf serum (FCS) supplemented with 10% dimethyl sulfoxide (DMSO) is under constant discussion by regulatory authorities [23] and [25], as there is the risk of transmitting potentially infectious agent [4] and [50]. It can also influence immunologic assessment studies done following thawing [3]. Ideally, media should be non-toxic, standardized and free of all undefined additives and possible sources of contamination and there have been an increasing number of attempts to create such standardized cryomedia [10], [14] and [36].

Comments are closed.